FDA APPROVES FIRST GENERIC OLANZAPINE TO TREAT SCHIZOPHRENIA, BIPOLAR DISORDER

The U.S. Food and Drug Administration (FDA) approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.

Press Release: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm277022.htm

This entry was posted in Uncategorized and tagged , , , , . Bookmark the permalink.